A Study of Pharmacokinetic Interaction Between Buspirone and Alprazolam at Steady State

The Journal of Clinical Pharmacology

Volumn 33, Issue 11, 1993, Pages 1104-1109

  Buch, A B ^a,b   Van Harken, D R ^a,b   Seidehamel, R J ^a,b   Barbhaiya, R H ^a,b  

^a BRISTOL MYERS SQUIBB COMPANY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BUSPIRONE; DRUG METABOLITE;

ADULT; AREA UNDER THE CURVE; ARTICLE; DROWSINESS; DRUG BLOOD LEVEL; DRUG SAFETY; ELECTRON CAPTURE DETECTION; GAS CHROMATOGRAPHY; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; STEADY STATE; VERTIGO;

ADMINISTRATION, ORAL; ADULT; ALPRAZOLAM; BUSPIRONE; COMPARATIVE STUDY; DRUG INTERACTIONS; HUMAN; MALE; TABLETS;

EID: 0027131568     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1993.tb01947.x     Document Type: Article

References (24)

1. Buspirone: Clinical profile of a new class of anxioselective agents
2. Neuropharmacology of buspirone
3. Investigation of the abuse liability of buspirone in alcohol dependent patients
4. A review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression
5. Determination of biological activity of alprazolam, triazolam and their metabolites
6. Buspirone treatment of anxiety in a patient dependent on alprazolam
7. Switching from alprazolam to buspirone
8. Detection of alprazolam (xanax) and its metabolites in urine using dual capillary column, dual nitrogen detector gas chromatography
9. Simultaneous quantitation of buspirone and 1‐(2‐pyrimidinyl) piperazine in human plasma and urine by capillary gas chromatography‐mass spectrometry
10. Management of pharmacokinetic data using hp‐3357/mainframe IBM interfacing
11. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time
12. Pharmacokinetics of newer benzodiazepines
13. The relationship of alprazolam dose to steady‐state plasma concentrations
14. 14C‐alprazolam, a new anxiolytic‐antidepressant in man
15. Pharmacokinetic consequences of long term administration of cimetidine and triazobenzodiazepines, alprazolam and triazolam in healthy subjects
16. Interaction of cimetidine with the trazolobenzodiazepines alprazolam and triazolam
17. Interaction of propoxyphene with diazepam, alprazolam and lorazepam
18. Lack of interaction between cimetidine and buspirone
19. Metabolism and toxicology of buspirone
20. The metabolism and disposition of buspirone